Unknown

Dataset Information

0

Elevated Cardiac Troponin to Detect Acute Cellular Rejection After Cardiac Transplantation: A Systematic Review and Meta-Analysis.


ABSTRACT: Cardiac troponin is well known as a highly specific marker of cardiomyocyte damage, and has significant diagnostic accuracy in many cardiac conditions. However, the value of elevated recipient troponin in diagnosing adverse outcomes in heart transplant recipients is uncertain. We searched MEDLINE (Ovid), Embase (Ovid), and the Cochrane Library from inception until December 2020. We generated summary sensitivity, specificity, and Bayesian areas under the curve (BAUC) using bivariate Bayesian modelling, and standardised mean differences (SMDs) to quantify the diagnostic relationship of recipient troponin and adverse outcomes following cardiac transplant. We included 27 studies with 1,684 cardiac transplant recipients. Patients with acute rejection had a statistically significant late elevation in standardised troponin measurements taken at least 1 month postoperatively (SMD 0.98, 95% CI 0.33-1.64). However, pooled diagnostic accuracy was poor (sensitivity 0.414, 95% CrI 0.174-0.696; specificity 0.785, 95% CrI 0.567-0.912; BAUC 0.607, 95% CrI 0.469-0.723). In summary, late troponin elevation in heart transplant recipients is associated with acute cellular rejection in adults, but its stand-alone diagnostic accuracy is poor. Further research is needed to assess its performance in predictive modelling of adverse outcomes following cardiac transplant. Systematic Review Registration: identifier CRD42021227861.

SUBMITTER: Liu Z 

PROVIDER: S-EPMC9215116 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elevated Cardiac Troponin to Detect Acute Cellular Rejection After Cardiac Transplantation: A Systematic Review and Meta-Analysis.

Liu Zhengyang Z   Perry Luke A LA   Penny-Dimri Jahan C JC   Handscombe Michael M   Overmars Isabella I   Plummer Mark M   Segal Reny R   Smith Julian A JA  

Transplant international : official journal of the European Society for Organ Transplantation 20220608


Cardiac troponin is well known as a highly specific marker of cardiomyocyte damage, and has significant diagnostic accuracy in many cardiac conditions. However, the value of elevated recipient troponin in diagnosing adverse outcomes in heart transplant recipients is uncertain. We searched MEDLINE (Ovid), Embase (Ovid), and the Cochrane Library from inception until December 2020. We generated summary sensitivity, specificity, and Bayesian areas under the curve (BAUC) using bivariate Bayesian mode  ...[more]

Similar Datasets

| S-EPMC7186718 | biostudies-literature
| S-EPMC5009413 | biostudies-literature
| S-EPMC8670586 | biostudies-literature
| S-EPMC2778785 | biostudies-other
| S-EPMC11637756 | biostudies-literature
| S-EPMC5484506 | biostudies-literature
| S-EPMC5347403 | biostudies-literature
| S-EPMC6528079 | biostudies-literature
| S-EPMC11617192 | biostudies-literature